Author:
Hosokawa Shota,Inoue Kazumasa,Takahashi Yasuyuki,Kawakami Kazunori,Kano Daisuke,Nakagami Yoshihiro,Fukushi Masahiro
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Physical Therapy, Sports Therapy and Rehabilitation,General Medicine,Radiation
Reference31 articles.
1. Medical Science and Pharmaceutical Committee Japan Radioisotope Association. Subcommittee on Survey of Nuclear Medicine Practice in Japan. The present state of nuclear medicine practice in Japan—a report of the 7th nationwide survey in 2012. Radioisotopes. 2013;62:545–608.
2. Nakai T, Okuyama C, Kubota T, Yamada K, Ushijima Y, Taniike K, Suzuki T, Nishimura T. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2005;32:1253–8.
3. Ohta M, Tokuda Y, Suzuki Y, Kubota M, Makuuchi H, Tajima T, Nasu S, Suzuki Y, Yasuda S, Shohtsu A. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun. 2001;22:875–9.
4. Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol. 2003;38:250–6.
5. Damle NA, Bal C, Bandopadhyaya GP, Kumar L, Kumar P, Malhotra A, Lata S. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan. Jpn J Radiol. 2013;31:262–9.